NCT02411942View on ClinicalTrials.gov

Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris

PHASE1CompletedINTERVENTIONAL
Enrollment

753

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Acne Vulgaris
Interventions
DRUG

Adapalene Gel 0.3%

Adapalene Gel 0.3% applied to the entire face once daily for 84 consecutive days

DRUG

Differin®

Differin® applied to the entire face once daily for 84 consecutive days

DRUG

Placebo

Placebo (vehicle of the test product) applied to the entire face once daily for 84 consecutive days

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT02411942 - Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter